Welcome! You are visiting the MyeloRx web site.

Home
About Us
Contact Us
Site Map
Lead Compounds
Clinical Efficacy - Leuke
Natural Products
Our Strategy
Intellectual Property
Targets
Acute Myeloid Leukemia
Lead Compound - MRx102
MRx102
AML Xenograft Model (MV4-
Pilot Toxicity
Summary
Targets
 
Acute Myeloid Leukemia (AML)
 
Immune-mediated Diseases
Organ Transplantation
Rheumatoid Arthritis - DMARD-like